RhopressaActive Ingredient(s): Netarsudil Dimesylate
FDA Approved: * December 18, 2017
Pharm Company: * AERIE PHARMS INC
Category: Vision / Eye Health
Netarsudil, sold under the brand name Rhopressa among others, is a medication for the treatment of glaucoma. In the United States, in December 2017, the Food and Drug Administration (FDA) approved a 0.02% ophthalmic solution for the lowering of elevated intraocular pressure in people with open-angle glaucoma or ocular hypertension. The European Medicines Agency approved it in 2019 for the same uses... [wikipedia]* May have multiple approval dates, manufacturers, or labelers.
Rhopressa .285 mg/ml Ophthalmic; Topical Solution/ DropsNDC: 70727-497
Aerie Pharmaceuticals Inc.